Details
Category: Volume 08 Issue 09 September 2020
Hits: 1084

Title: Clinico-Epidemiology Profile of Molar Pregnancy in Tertiary Care Centre: A Retrospective Review of Medical Records

Authors: Dr Vinod, Dr Kalpana Mehta, Dr Vimla Choudhary, Dr Ramniwas, Dr Anusha

 DOI: https://dx.doi.org/10.18535/jmscr/v8i9.11

Abstract

Background: Gestational trophoblastic disease (GTD) includes a series of disorders that are characterized by an abnormal proliferation of trophoblastic tissue with varying tendency to spontaneous remission, local invasion and metastasis. The incidence of GTD varies greatly in different parts of the world.  Hydatidiform mole presents with amenorrhea, painless vaginal bleeding and spontaneous passage of grape-like vesicles, high serum and urinary β human chorionic gonadotrophin (βHCG) levels.

Objective: To study epidemiology & clinical profile of Gestational Trophoblastic Disease and to evaluate its management and outcome.

Material and Methods: A retrospective study was conducted over a period of five years in MDM Hospital, Jodhpur. A total of 39301 pregnancies were recorded during the period of five years. The demographic profile, clinical presentation, management and complications were studied.

Results: There were 60 patients of GTD with an incidence of 1.52 per 1,000 pregnancies. Among these 60 cases, 45 (75%) cases had complete H mole. Most of the patients (63.3%) were in age group of 21-30 years and majority in nulliparous women (38.3%). Majority of the molar pregnancy cases 83.3% cases have been detected in the second trimester. The most common clinical presentation was bleeding per vaginum constituting 58.3% of cases. Majority (85%) of the patients were treated by suction and evacuation.

Conclusion: Gestational Trophoblastic Disease requires early diagnosis, treatment and strict monitoring to be 100% curable. Routine check-up helps to timely management of the GTDs thereby preventing their progression to GTN.

Keywords: Gestational Trophoblastic Disease, Hydatidiform Mole, Molar Pregnancy,   Neoplasia, Serum beta HCG.

References

  1. Lybol C, Thomas CMG, Bulten J, van Dijck JAAM, Sweep FCGJ, Massuger LFAG. Increase in the incidence of gestational trophoblastic disease in The Netherlands. Gynecol Oncol. 2011;1; 121 (2):334–8.
  2. J. Seckl, N.J. Sebire, R.A. Fisher, F. Golfier, L. Massuger, C. Sessa, ESMO Guidelines Working Group. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol. 24 (Suppl. 6) (2013) vi39–vi50.
  3. Nevin J, Bloch B, Dehaeck K, Soeters R. Gestational trophoblastic disease. Manual of Practical Gynaecological Oncology. London: Chapman and Hall; 1995:130–46.
  4. Moore LE, Hernandez E. Hydatidiform Mole [Internet]. Medscape Reference, Web MD LLC. 2014 [cited 2014 Dec 10]. Available from: http://emedicine.medscape.com/article/254657-overview#showall
  5. Chhabra A, Sinha P. Gestational Trophoblastic Disease – some observation. J ObsGynecol India. 1988;38:590–3.
  6. Thapa K, Shrestha M, Sharma S, Pandey S. Trend of complete Hydatidiform mole. J Nepal Med Assoc. 2010;49(1):10–3.
  7. Garret LA, Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med. 2008;53(7):481–6.
  8. Kumar N, Saxena Y K, Rathi AK Host and risk factor for GTD: A hospital based analysi from India. Med Sci. Monit 2003;9(10):442-7.
  9. org>chapter-3-epidemiology; page 58, table 3.2.
  10. Goldstein DP, Berkowitz RS. Gestational trophoblastic neoplasms: Clinical principles of disgnosis and treatment. Philadelphia: W B Saunders; 1982:1–301.
  11. Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973–83. Lancet. 1986;328(8508):70–4.
  12. Evans AC, Soper JT, Hammond CB. Clinical features of molar pregnancies and gestational trophoblastic tumours. ObstetGynaecol. 2003;87:182–205.
  13. Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J gynecol Cancer 2001;11:73-7
  14. Jethwani L, Choudhary R, Bhati I, Choudhary V Clinico-Epidemiological Profile of Molar Pregnancies at A Tertiary Care Centre of India: A Prospective Observational Study. International journal of Scientific Research 2007;6(7):45-8
  15. Rauf B Hassan Rauf B, Hassan L, Ahmed S. Management of gestational trophoblastic tumors: a five-year clinical experience. J Coll Physicians Surg Pak 2004;14:540-4
  16. Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and an etiology of gestational trophoblastic disease. Lancet Oncol 2003;4:670
  17. Farhat Khanum, Sadia Shamsher. Gestational trophoblastic disease: experience at a tertiary care hospital of Peshawar. Jpmi 2010;24(02):127-32
  18. Ramesh Chandran Jyoti Ramesh Chandran, Uma Devi N, Sumangala Devi, Sajala Vimal Raj. Epidemiology of Complete Hydatidiform Mole at a Tertiary Hospital and Analysis of Cases over Last 5 Year Period. Indian Journal of Maternal and Child Health 2011;13(4):1-8
  19. Vaidya A. Molar Pregnancy - Clinical Trends at Maternity Hospital. Postgraduate medical journal of national academy of medical science 2008;8(1):1-6.
  20. Ochecki Amaka N Ocheke, Jonah Musa, Alexander O Uamai. Hydatidiform mole in Jos, Nigeria. Niger Med J 2011;52(4):223–6.
  21. Parazzini F, LaVecchia C, Mangili G. Dietary factors and risk of trophoblastic disease. Am J Obstet Gynecol 1988;158:93-9.
  22. Sebire NJ, Foskett M, Short D, Savage P, Stewart W, Thomson M et al. Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit. BJOG 2007; 114(6):760-2
  23. Fatima M, Kasi PM, Baloch SN, Kassi M, Marri SM, Kassi M Incidence, Management and Outcome of molar pregnancies at tertiary care hospital in Quetta, Pakistan. ISRN ObsGynecol 2011; 925316
  24. Madhuri Chinthalal, D Srividya Sarma Gestational trophoblastic disease: study on incidence and management at a tertiary centre. Indian Journal of Basic and Applied Medical Research; December 2017;7(1):317-24
  25. Jangbhadur Singh, Shaveta Sharma, KirpalKour, Shazia Bashir. Prevalance of molar pregnancy (a three-year retrospective study) in a tertiary care hospital. Annals of Applied Bio-Sciences 2016;3(1):1-4
  26. Nousheen Aziz, Sajida Yousfani, Irfanullah Soomro, Firdaus Mumtaz, Gestational Trophoblastic Disease, www.ayubmed.edu.pk/JAMC/24-1
  27. Lakra P, Vijayata Sangwan, Sunita Siwach, Richa Kansal, Rajiv Mahendru, Anjali Sharma. Outcome of gestational trophoblastic disease in a rural tertiary centre of Haryana, India. Int J Reprod Contracept Obstet Gynaecol 2017; 6(1):271-5.
  28. Santos-Ramos R, Forney JP, Schwarz BE. Sonographic findings and clinical correlations in molar pregnancy. Obstet Gynecol 1980; 56:186-92
  29. Benson CB, Genest DR, Bernstein MR, Soto-Wright V, Goldstein DP, Berkowitz RS. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound ObstetGynecol2000;16:188-91
  30. Hancock BW, Tidy JA. Current management of molar pregnancy. J Reprod Med 2002;47:347-54
  31. Soper JT. Surgical therapy for gestational trophoblastic disease. J Reprod Med 1994; 39:168-74.

Corresponding Author

Dr Vinod

Department of Obstetrics and Gynaecology, MDM Hospital, Dr. S. N. Medical College, Jodhpur, Rajasthan